Effects of Modified Tobacco Risk Products with Claims and Nicotine Features on Perceptions among Racial and Ethnic Groups

Author:

DeAtley Teresa1ORCID,Johnson Andrea C.1ORCID,Stone Matthew D.2ORCID,Audrain-McGovern Janet1ORCID,Mercincavage Melissa1ORCID,Strasser Andrew A.1ORCID

Affiliation:

1. Department of Psychiatry and Tobacco Center of Regulatory Science, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA

2. Herbert Wertheim School of Public Health and Human Longevity Science, University of California, San Diego, CA 92093, USA

Abstract

Research suggests consumers may misunderstand modified risk tobacco product (MRTP) claims. We examined the effects of nicotine content across four tobacco products with and without MRTP claims among a racially and ethnically diverse sample of adults who do and do not smoke. Adults (n = 1484) aged 21–65 completed an online experiment using a 2 × 2 × 4 mixed factorial design to examine the effects of tobacco product (Classic White Snus, IQOS, JUUL e-cigarette, and VLN cigarette) and nicotine content (high vs. low) stratified by MRTP claim (present vs. absent) across four outcomes: (1) likely to try (2) serious disease if used regularly, (3) least addictive, and (4) ease of quitting smoking. Not including an MRTP claim resulted in an increased likelihood of trying a product, decreased concern of serious disease, lower perceived addictiveness, and increased ease of quitting smoking. Participants selected low nicotine IQOS without a claim as the least likely to cause serious disease. Low nicotine JUUL, without a claim, was selected as least addictive and most likely to facilitate quitting. Intentions to try were highest for low nicotine JUUL. Participants selected low-nicotine products as less addictive than high nicotine products. Regulatory efforts should consider how MRTP claims interact with different product characteristics. Subtle differences exist across outcomes between racial and ethnic groups, which indicates that further research is warranted.

Funder

National Cancer Institute

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Reference46 articles.

1. Food and Drug Administration (2022, November 23). Section 911 of the Federal Food, Drug, and Cosmetic Act-Modified Risk Tobacco Products. FDA. Published Online 21 July 2020, Available online: https://www.fda.gov/tobacco-products/rules-regulations-and-guidance/section-911-federal-food-drug-and-cosmetic-act-modified-risk-tobacco-products.

2. Food and Drug Administration (2022, September 28). Modified Risk Granted Orders. FDA. Published Online 15 August 2022, Available online: https://www.fda.gov/tobacco-products/advertising-and-promotion/modified-risk-granted-orders.

3. Wackowski, O.A., Rashid, M., Greene, K.L., Lewis, M.J., and O’Connor, R.J. (2020). Smokers’ and Young Adult Non-Smokers’ Perceptions and Perceived Impact of Snus and E-Cigarette Modified Risk Messages. Int. J. Environ. Res. Public Health, 17.

4. Effects of IQOS health warnings and modified risk claims among young adult cigarette smokers and non-smokers;Mays;Tob. Control,2023

5. Rubenstein, D., Denlinger-Apte, R.L., Cornacchione Ross, J., Carroll, D.M., and McClernon, F.J. (2023). Older age is associated with greater misperception of the relative health risk of e-cigarettes and cigarettes among US adults who smoke. Tob. Control, Epub ahead of printing.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3